187 related articles for article (PubMed ID: 36028573)
1. Radiation Segmentectomy for the Treatment of Primary Hepatic Malignancies of the Caudate Lobe: A Case Series.
Arora M; Toskich BB; Lewis AR; Padula CA; Montazeri SA; Ritchie C; Frey G; Paz-Fumagalli R; McKinney JM; Devcic Z
Cardiovasc Intervent Radiol; 2022 Oct; 45(10):1485-1493. PubMed ID: 36028573
[TBL] [Abstract][Full Text] [Related]
2. Yttrium-90 Radiation Segmentectomy of Hepatocellular Carcinoma: A Comparative Study of the Effectiveness, Safety, and Dosimetry of Glass-Based versus Resin-Based Microspheres.
Villalobos A; Arndt L; Cheng B; Dabbous H; Loya M; Majdalany B; Bercu Z; Kokabi N
J Vasc Interv Radiol; 2023 Jul; 34(7):1226-1234. PubMed ID: 36958669
[TBL] [Abstract][Full Text] [Related]
3. Segmental Yttrium-90 Radioembolization Using Glass Microspheres Greater than 400 Gray for the Treatment of Intrahepatic Cholangiocarcinoma: A Preliminary Experience.
Yu Q; Patel M; Kwak D; Ungchusri E; Wang Y; Van Ha T; Zangan S; Marshall E; Little K; Baker T; Liao CY; Pillai A; Ahmed O
J Vasc Interv Radiol; 2023 Nov; 34(11):1970-1976.e1. PubMed ID: 37532096
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of Surgical Resection after Radioembolization for Hepatocellular Carcinoma.
Gabr A; Abouchaleh N; Ali R; Baker T; Caicedo J; Katariya N; Abecassis M; Riaz A; Lewandowski RJ; Salem R
J Vasc Interv Radiol; 2018 Nov; 29(11):1502-1510.e1. PubMed ID: 30268638
[TBL] [Abstract][Full Text] [Related]
5. Repeated Treatment with
Filippi L; Di Costanzo GG; Tortora R; Pelle G; Cianni R; Schillaci O; Bagni O
Cancer Biother Radiopharm; 2019 May; 34(4):231-237. PubMed ID: 30758985
[No Abstract] [Full Text] [Related]
6. Determination of Tumor Dose Response Thresholds in Patients with Chemorefractory Intrahepatic Cholangiocarcinoma Treated with Resin and Glass-based Y90 Radioembolization.
Cheng B; Villalobos A; Sethi I; Wagstaff W; Galt J; Brandon D; Schuster DM; Bercu Z; Majdalany B; Kokabi N
Cardiovasc Intervent Radiol; 2021 Aug; 44(8):1194-1203. PubMed ID: 33890170
[TBL] [Abstract][Full Text] [Related]
7. Relationship of Tumor Radiation-absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with
Hermann AL; Dieudonné A; Ronot M; Sanchez M; Pereira H; Chatellier G; Garin E; Castera L; Lebtahi R; Vilgrain V;
Radiology; 2020 Sep; 296(3):673-684. PubMed ID: 32602828
[TBL] [Abstract][Full Text] [Related]
8. Survival and Toxicities after Yttrium-90 Transarterial Radioembolization of Cholangiocarcinoma in the RESiN Registry.
Robinson TJ; Du L; Matsuoka L; Sze DY; Kennedy AS; Gandhi RT; Kouri BE; Collins ZS; Kokabi N; Grilli CJ; Wang EA; Lee JS; Brown DB
J Vasc Interv Radiol; 2023 Apr; 34(4):694-701.e3. PubMed ID: 36509236
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of Yttrium-90 Radioembolization for Unresectable Combined Biphenotypic Hepatocellular-Cholangiocarcinoma.
Malone CD; Gibby W; Tsai R; Kim SK; Lancia S; Akinwande O; Ramaswamy RS
J Vasc Interv Radiol; 2020 May; 31(5):701-709. PubMed ID: 32127318
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of radioembolization with glass microspheres in hepatocellular carcinoma patients with elevated lung shunt fraction: analysis of a 103-patient cohort.
Das A; Riaz A; Gabr A; Ali R; Mora R; Al Asadi A; Mouli S; Lewandowski RJ; Salem R
Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):807-815. PubMed ID: 31502015
[TBL] [Abstract][Full Text] [Related]
11. Pathologic Response of Hepatocellular Carcinoma Treated with Yttrium-90 Glass Microsphere Radiation Segmentectomy Prior to Liver Transplantation: A Validation Study.
Toskich B; Vidal LL; Olson MT; Lewis JT; LeGout JD; Sella DM; Montazeri SA; Devcic Z; Lewis AR; Frey GT; Ritchie CA; Paz-Fumagalli R; Croome KP; Patel TC
J Vasc Interv Radiol; 2021 Apr; 32(4):518-526.e1. PubMed ID: 33551304
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the Effectiveness of Yttrium-90 Glass Microspheres in the Treatment of Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, and Metastatic Colorectal Cancer in Practice: Protocol for the Prospective PROACTIF Phase IV Registry Study in France.
Garin E; Pinaquy JB; Bailly C; Sengel C; Mariano-Goulart D; Edeline J; Blanc JF; Bouvier A; Tordo J; Rode A; Becker S; Sefrioui D; de Baere T; Somma C; Mastier C; Goupil J; Chevallier P; Regnault H; Vibert E; Manfredi S; Vicaut E; Patel B; Boucher E; Guiu B;
Cardiovasc Intervent Radiol; 2022 Jan; 45(1):1-11. PubMed ID: 34796373
[TBL] [Abstract][Full Text] [Related]
13. Radioembolization with Yttrium-90 Glass Microspheres as a First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma-A Prospective Feasibility Study.
Kis B; Shridhar R; Mhaskar R; Gyano M; Frakes JM; El-Haddad G; Choi J; Kim RD; Hoffe SE
J Vasc Interv Radiol; 2023 Sep; 34(9):1547-1555. PubMed ID: 37210030
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of Boosted Radioembolization for Hepatocellular Carcinoma Larger than 5 cm.
Kim HC; Kim YJ; Lee JH; Suh KS; Chung JW
J Vasc Interv Radiol; 2019 Jan; 30(1):1-8. PubMed ID: 30293734
[TBL] [Abstract][Full Text] [Related]
15. Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival.
Hoffmann RT; Paprottka PM; Schön A; Bamberg F; Haug A; Dürr EM; Rauch B; Trumm CT; Jakobs TF; Helmberger TK; Reiser MF; Kolligs FT
Cardiovasc Intervent Radiol; 2012 Feb; 35(1):105-16. PubMed ID: 21431970
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of repeat Y90 radioembolization to the same hepatic arterial territory.
Badar W; Van Ha T; Zangan S; Navuluri R; Pillai A; Baker T; Dalag L; Han R; Ahmed O
Br J Radiol; 2021 Mar; 94(1119):20200752. PubMed ID: 33411569
[TBL] [Abstract][Full Text] [Related]
17. Analysis of dynamic hepatobiliary contrast-enhanced MRI signal intensity after Yttrium-90 radioembolization with glass microspheres for the treatment of hepatocellular carcinoma.
Syed M; Shah J; Montazeri SA; Grajo JR; Geller B; Toskich B
Abdom Radiol (NY); 2021 May; 46(5):2182-2187. PubMed ID: 33216180
[TBL] [Abstract][Full Text] [Related]
18. Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis.
Mouli S; Memon K; Baker T; Benson AB; Mulcahy MF; Gupta R; Ryu RK; Salem R; Lewandowski RJ
J Vasc Interv Radiol; 2013 Aug; 24(8):1227-34. PubMed ID: 23602420
[TBL] [Abstract][Full Text] [Related]
19. Superselective yttrium-90 radioembolization for hepatocellular carcinoma yields high response rates with minimal toxicity.
Padia SA; Kwan SW; Roudsari B; Monsky WL; Coveler A; Harris WP
J Vasc Interv Radiol; 2014 Jul; 25(7):1067-73. PubMed ID: 24837982
[TBL] [Abstract][Full Text] [Related]
20. Resin Versus Glass Microspheres for
Van Der Gucht A; Jreige M; Denys A; Blanc-Durand P; Boubaker A; Pomoni A; Mitsakis P; Silva-Monteiro M; Gnesin S; Lalonde MN; Duran R; Prior JO; Schaefer N
J Nucl Med; 2017 Aug; 58(8):1334-1340. PubMed ID: 28082436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
